![]() |
Volumn 10, Issue 8, 2002, Pages 2779-2793
|
Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID;
5,8 ETHANO 1 (3,4,5 TRIMETHOXYBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 1 (3,4,5 TRIMETHOXYBENZYL) 5,6,7,8 TETRAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 CHLOROBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 CHLOROBENZYL) 2 (4 METHOXYBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 CHLOROBENZYL) 2 METHYL 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 CHLOROBENZYL) 2,2 DIMETHYL 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE IODIDE;
5,8 ETHANO 1 (4 CHLOROBENZYL) 5,6,7,8 TETRAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 METHOXYBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 METHOXYBENZYL) 5,6,7,8 TETRAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 METHYLBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 1 (4 METHYLBENZYL) 5,6,7,8 TETRAHYDROISOQUINOLINE;
5,8 ETHANO 1,2 DI (4 METHOXYBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 2 (4 METHOXYBENZYL) 1 (3,4,5 TRIMETHOXYBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 2 (4 METHOXYBENZYL) 1 (4 METHYLBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 2 FORMYL 1 (4 CHLOROBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 2 METHYL 1 (3,4,5 TRIMETHOXYBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
5,8 ETHANO 2 METHYL 1 (4 METHYLBENZYL) 1,2,3,4,5,6,7,8 OCTAHYDROISOQUINOLINE;
7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID;
ISOQUINOLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTITHROMBOCYTIC AGENT;
FUSED HETEROCYCLIC RINGS;
PROSTAGLANDIN RECEPTOR;
THROMBOXANE A2 RECEPTOR;
THROMBOXANE RECEPTOR;
ARTICLE;
CONTROLLED STUDY;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
OXIDATION;
RECEPTOR AFFINITY;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE AGGREGATION;
DRUG ANTAGONISM;
DRUG EFFECT;
IC 50;
PROTEIN BINDING;
SYNTHESIS;
BICYCLO COMPOUNDS, HETEROCYCLIC;
HUMANS;
INHIBITORY CONCENTRATION 50;
ISOQUINOLINES;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
PROTEIN BINDING;
RECEPTORS, PROSTAGLANDIN;
RECEPTORS, THROMBOXANE;
RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 18444366474
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00101-3 Document Type: Article |
Times cited : (10)
|
References (69)
|